Valye reports for unlimited access

BRC Group Holdings, Inc. is a diversified holding company offering a platform of businesses including financial services, telecom, retail, and investments in equity, debt, and venture capital. The company provides customized financial solutions to small cap and middle market companies, complemented by banking and wealth management services. Its telecom businesses offer a range of communication services, while consumer products include mobile computing accessories and home furnishings. The company actively invests in and acquires companies or assets with attractive risk-adjusted returns, focusing on operational improvements to maximize free cash flow. BRC Group has been focused on reducing indebtedness through operating cash flow and strategic asset dispositions, lowering total debt from $1.8 billion at the end of 2024 to $1.4 billion at the end of 2025. The company operates seven reportable segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Capital Markets includes investment banking, brokerage, direct lending, equity research, and proprietary trading. Wealth Management offers brokerage, investment management, insurance, and tax services with $13 billion in assets under management. Telecom segments provide traditional and cloud-based communication services. Consumer Products segment includes Targus, a global manufacturer of productivity products. The company faces intense competition across all lines and is subject to extensive regulation.

LFTD Partners Inc. is a holding company whose primary operations are conducted through its wholly owned subsidiary Lifted Liquids, Inc. (Lifted), which manufactures and sells hemp-derived and other psychoactive products under brands such as Urb Finest Flowers, Mielos, and Rebel Energy Gummy. Lifted also serves as the exclusive manufacturer and seller of Diamond Supply Co. hemp-derived products. The company’s sales are predominantly to distributors, wholesalers, private label clients, and end consumers within the United States. LFTD Partners holds minority investments in hemp-derived beverage maker Ablis and craft distiller Bendistillery. The company’s revenue recognition follows ASC 606 standards, and it faces operational challenges including delayed customer payments and regulatory uncertainties. The company has recorded significant impairment charges in 2025 due to regulatory developments affecting the hemp industry. LFTD Partners trades on the OTCQB Venture Market under the ticker LIFD.

Monopar Therapeutics is a clinical-stage biopharmaceutical company engaged in research and development of product candidates. The company has not yet generated revenue and focuses on advancing its pipeline through clinical trials and regulatory approvals. It operates as a single reportable segment with the CEO as the chief operating decision maker. The company’s financial position as of December 31, 2025, shows a net loss and significant cash reserves, supporting ongoing operations. Monopar has issued pre-funded warrants classified as equity and has reported research and development expenses related to clinical trials and licensing agreements.

Zeo Energy Corp. is a vertically integrated residential solar energy company focused on accelerating the U.S. transition to renewable energy by providing affordable and sustainable solar energy solutions. The company offers a full suite of services including sale, design, procurement, installation, and maintenance of residential solar energy systems. Its customer base is primarily located in Florida, Texas, Arkansas, Missouri, Ohio, and Illinois, with expanding operations in additional states such as California and Colorado. Zeo Energy also provides complementary energy efficiency products and roofing services, leveraging a combination of internal sales agents and external dealers to market its offerings. The company has expanded its market presence through acquisitions, including Heliogen, a technology-focused renewable energy firm, and assets from Lumio HX, Inc. Financially, Zeo Energy reported revenues of approximately $69.35 million and a net loss of $14.01 million for the fiscal year ended December 31, 2025, with liquidity ratios reflecting a current ratio of 2.69 and cash ratio of 0.73. The company’s business model emphasizes vertical integration to improve project execution and customer satisfaction, while facing risks related to supply chain, inflation, regulatory environment, and internal controls.

THEGLOBE.COM, INC. was incorporated in 1995 and originally operated as an online community. In 2008, it sold its last operating business and became a shell company with no material operations or assets. Since then, the company has had no employees and no revenue. Its operating expenses consist mainly of public company costs such as legal, audit, and administrative fees. The majority stockholder, Delfin Midstream Inc., owns approximately 70.9% of the company and provides loans to fund operations. The company’s financial position shows a net working capital deficit and accumulated losses exceeding $298 million as of late 2025. The company’s common stock is delisted from NASDAQ and trades on the OTC Bulletin Board, subject to penny stock regulations.

RH is a luxury lifestyle brand and retailer specializing in home furnishings across multiple categories such as furniture, lighting, textiles, bathware, décor, outdoor and garden, and baby, child and teen furnishings. The company operates a fully integrated sales platform that includes retail galleries, interior design studios, Waterworks showrooms, websites, Sourcebooks, trade and contract channels, and outlet stores. RH's retail footprint includes 89 locations across North America and Europe, with ongoing global expansion efforts. The company emphasizes product elevation, proprietary product development, and a membership program that drives the majority of its sales. RH sources products globally, primarily from Asia and North America, and manages distribution through multiple centers and home delivery services. The brand positions itself as a design authority and competes on style, quality, and breadth of assortment in a competitive market [S1].

Maui Land & Pineapple Company, Inc. is a landholding and operating company with principal subsidiaries, owning approximately 22,300 acres of land and 247,000 square feet of commercial property on Maui, Hawai‘i. The company’s operations are organized into three business segments: Land Development and Sales, Leasing, and Resort Amenities. The Land Development and Sales segment focuses on planning, entitlement, development, and sales of residential, resort, commercial, agricultural, and industrial real estate, with the Kapalua Resort as its principal development. The Leasing segment includes commercial, agricultural, and industrial leases, trademark licensing, water system management, and conservation stewardship. The Resort Amenities segment operates the Kapalua Club, offering members access to resort amenities. The company reported total revenues of approximately $19.5 million and a net loss of $10.6 million for the year ended December 31, 2025. Liquidity ratios indicate a current ratio of 1.24 and a cash ratio of 0.72 as of year-end 2025. The company faces risks related to economic conditions, real estate market cyclicality, regulatory approvals, competition, and financing availability.

Jeffs' Brands Ltd, now Nexera Technologies Ltd, was incorporated in March 2021 in Israel. It operates a data-driven e-commerce business primarily on Amazon using the FBA model, selling various consumer products. The company has expanded into the global homeland security sector, focusing on AI-driven security solutions through its subsidiary KeepZone AI. It owns several subsidiaries including Fort Technology and Pure Logistics, the latter operating a logistics center in New Jersey to support supply chain and third-party services. The company has entered multiple reseller and distribution agreements for advanced security technologies, targeting major events such as the FIFA World Cup 2026. Jeffs' Brands has undergone acquisitions to strengthen its market position and supply chain capabilities. The company is in a corporate rebranding and restructuring phase to align with its strategic focus on homeland security and advanced technologies.

XWELL, Inc. operates as a global wellness organization focused on delivering health and wellness services primarily to travelers. Its three reportable segments are XpresSpa, which offers spa services and travel products at major airports; XpresTest, which transitioned from COVID-19 testing to bio-surveillance programs supported partially by government contracts; and Naples Wax Center, which provides hair removal and skincare services through multiple locations. The company has ceased its HyperPointe marketing support business as of the end of 2025. XWELL’s strategy involves expanding and integrating its wellness products and services, optimizing its airport portfolio, and pursuing acquisitions to grow its presence in the wellness sector. The company’s revenue is generated mainly in the United States with additional contributions from international markets including the Netherlands, Turkey, and the United Arab Emirates. XWELL’s operations are sensitive to air travel trends and airport passenger traffic, which influence demand for its services.

NOVAGOLD RESOURCES INC operates in the gold mining sector, primarily focused on the Donlin Gold project in Alaska. The project is held through Donlin Gold LLC, a joint venture between NOVAGOLD and Donlin Gold Holdings LLC (Paulson entities). The company does not currently produce gold or generate operating earnings and funds its activities through equity offerings, convertible notes, and asset sales. The Donlin Gold project is located on Alaska Native-owned land and state mining claims, with leases from Calista Corporation and The Kuskokwim Corporation. NOVAGOLD has a small workforce supplemented by consultants and emphasizes diversity and inclusion. The company is advancing the Donlin Gold project through feasibility studies, drilling, and community engagement, with a 2026 budget allocated to these activities. Financially, NOVAGOLD maintains a strong liquidity position with over $117 million in cash and equivalents as of February 2026, but reported a net loss in the recent quarter. The company carries a significant promissory note payable to Barrick Mining Corporation related to the Donlin Gold project. Recent news highlights include financing activities and leadership appointments to support project advancement.

Sidus Space Inc. is a Delaware-incorporated emerging growth company headquartered in Merritt Island, Florida, operating in the aerospace and defense sector with a focus on satellite technology and communications. The company has engaged in capital raising activities through registered direct offerings and at-the-market sales agreements to support its growth initiatives. Sidus Space reported a 36% increase in revenue in 2025 and has formed strategic partnerships to advance its satellite communication capabilities. The company reported a net loss for the fiscal year ended December 31, 2025, and maintains a liquidity position with a current ratio above 3.0. Sidus Space's business model includes product development, manufacturing expansion, and operational scaling funded by equity offerings.

First America Resources Corporation, incorporated in 2010 and headquartered in Morris, Illinois, operates primarily through its subsidiary METech Recycling, which has a long history in precious metal recovery and electronics recycling. The company provides IT asset disposition services including refurbishment, resale, secure data destruction, and electronics recycling. It also offers specialized services for AI infrastructure lifecycle management and data center decommissioning. The company handles a broad range of IT and electronic products, including emerging technology equipment such as solar panels and electric vehicle batteries. It serves a diverse customer base across technology, telecommunications, defense, education, and government sectors, including Fortune 500 companies. The company leverages internally developed and third-party software systems with AI and machine learning to enhance operational efficiency, asset classification, and pricing. Facilities are located across several U.S. states, supporting logistics and processing activities. The company maintains environmental compliance programs and holds R2v3 Responsible Recycler certification. Financially, the company reported revenues of $18.79 million and a net income of $2,765 for the fiscal year ending December 31, 2025, with liquidity ratios indicating some working capital constraints.

Aura Minerals Inc. is a mining company focused on gold and copper production in the Americas, operating six wholly-owned mines in Honduras, Brazil, and Mexico. The company pursues growth through acquisitions, mine expansions, and operational improvements, emphasizing sustainability and efficient capital deployment. Key operating mines include Minosa, Almas, Apoena, Borborema, MSG, and Aranzazu. Development projects include Matupá in Brazil, which features detailed mineral resource and reserve estimates prepared under S-K 1300 standards. The company reported significant revenue growth in 2025 driven by higher metal prices and production from new mines. Aura Minerals manages a diversified customer base for its gold and copper products and maintains a disciplined approach to capital expenditures and debt management.

Aura Minerals Inc. is a gold and copper mining company with operations primarily in the Americas, including Honduras, Brazil, Mexico, and Guatemala. The company operates six wholly-owned mines and is developing several projects, including the Matupá Gold Project in Brazil. Aura Minerals emphasizes operational efficiency, sustainable mining practices, and disciplined capital allocation to generate cash flow and dividends. The company holds extensive mineral rights and actively pursues exploration to expand its resource base. Its processing facilities employ advanced metallurgical techniques such as carbon-in-leach and cyanide detoxification. Financially, Aura Minerals reported significant revenue growth in 2025 driven by higher metal prices and production from new mines, alongside increased capital expenditures for project development. The company manages debt with various financial covenants and collateral arrangements and maintains relationships with major customers for gold and copper concentrate sales [S1][S2].

MicroAlgo Inc. develops and applies bespoke central processing algorithms integrated with software and hardware to optimize digital services, primarily serving the internet multimedia video advertising sector. The company’s services include algorithm optimization, accelerating computing power without hardware upgrades, lightweight data processing, and data intelligence services. Historically, revenue was also generated from intelligent chips and services, but this segment was discontinued after 2023. The company’s revenue has declined in recent years due to market demand shifts and economic uncertainty, with a focus on maintaining profitability and operational efficiency. MicroAlgo is expanding its technology applications into quantum information systems and combinatorial optimization algorithms, aiming to broaden its customer base beyond advertising into finance, retail, logistics, and other industries. The company maintains strong liquidity and has completed convertible note issuances converted into equity to support operations and debt repayment.

Innate Pharma SA is a French clinical-stage biotechnology company focused on developing innovative immunotherapies that harness the innate immune system to treat cancer. The company’s therapeutic approaches include monoclonal antibodies, multispecific NK Cell Engagers via its proprietary ANKET® platform, and Antibody Drug Conjugates (ADC). Its pipeline features proprietary programs such as lacutamab for cutaneous and peripheral T cell lymphomas, monalizumab developed in collaboration with AstraZeneca for non-small cell lung cancer, and several ANKET® candidates targeting various tumor types. Innate Pharma maintains strategic collaborations and licensing agreements with major pharmaceutical companies including AstraZeneca, Sanofi, and Takeda, which provide upfront payments, milestone payments, and research funding. The company’s revenue primarily derives from these collaborations and government research financing. Financially, Innate Pharma reported €9.0 million in revenue and a net loss of €49.2 million for the fiscal year ended December 31, 2025. The company held €28.1 million in cash and equivalents and had a current ratio of 1.27 at year-end 2025. Liquidity is sufficient to fund operations through the third quarter of 2026, with additional financing needed thereafter. The company has incurred net losses historically due to research and development and administrative expenses. Recent developments include FDA breakthrough therapy designation for lacutamab and workforce reductions to manage costs.

ASE Technology Holding Co., Ltd. operates as a leading semiconductor manufacturing services company specializing in assembly and testing. Its business segments include Advanced Technology Manufacturing (ATM), covering packaging and testing, and Electronic Manufacturing Services (EMS). The company offers turnkey solutions including front-end engineering test, wafer probing, final test, packaging, materials, and EMS products. ASE has a global presence with manufacturing and R&D facilities across Asia, the Americas, and Europe. The company focuses on advanced packaging technologies such as BGA, SiP, and high-frequency testing solutions, collaborating closely with substrate suppliers and customers to enhance production capabilities and technology adoption. ASE reported consolidated revenues of approximately US$20.57 billion and net income of about US$1.31 billion for the fiscal year ended December 31, 2025. The company maintains a strong liquidity position with a current ratio of 1.26 and cash ratio of 0.37 as of the same date. ASE invests significantly in research and development, dedicating over 14,000 employees and allocating over 5% of revenues to R&D activities. The company’s dividend policy includes cash dividends of not less than 30% of total dividends, with residual dividends paid in stock, subject to earnings and legal reserve requirements. ASE’s customer base is concentrated, with the top five customers accounting for about 41% of net revenues in packaging and testing segments and about 70% in EMS. The company actively manages foreign currency exchange risks through hedging instruments. ASE’s shares trade on the Taiwan Stock Exchange and its ADSs on the NYSE.

Scinai Immunotherapeutics Ltd. is an Israeli biopharmaceutical company with two complementary business units: a research and development (R&D) segment focused on inflammation and immunology therapeutics, and a contract development and manufacturing organization (CDMO) segment operating through its subsidiary Scinai Biopharma Services Ltd. The R&D unit is developing a pipeline based on NanoAbs (nanosized antibody fragments) and the PC111 monoclonal antibody program, collaborating with leading academic institutions such as the Max Planck Society and University Medical Center Göttingen. The CDMO business provides integrated development and cGMP manufacturing services for early-stage biotech clients, supported by facilities in Jerusalem and Yavne, Israel, following the acquisition of Recipharm Israel Ltd. in February 2026. The company has a history of clinical trials, including a large phase 3 trial for a universal influenza vaccine candidate that did not meet endpoints, prompting a strategic refocus. Financially, the company reported revenues of $1.31 million and a net loss of $8.3 million for the year ended December 31, 2025, with liquidity constraints noted. The company continues to raise capital through equity offerings and grants to support operations and growth.

Aegon Ltd. operates as a global financial services holding company offering investment, protection, and retirement products. Its portfolio includes fully owned businesses in the US and UK, a global asset manager, insurance joint ventures in multiple countries, and strategic shareholdings. Headquartered in the Netherlands and domiciled in Bermuda, Aegon is listed on major exchanges. The company reported EUR 21.3 billion revenue in 2022 and EUR 980 million net income in 2025. It manages capital through share buybacks and strategic asset management, with a focus on sustainability and ESG integration. Aegon is in the process of relocating its legal domicile and head office to the US and plans to rename as Transamerica. The CEO's term extension reflects a focus on leadership continuity during this transformation.

Aura Minerals Inc. is a gold and copper mining company with operations across the Americas, including six wholly-owned mines in Honduras, Brazil, and Mexico. The company pursues growth through strategic acquisitions, mine expansions, and operational efficiencies, emphasizing sustainable mining practices and disciplined capital allocation. Key development projects include the Matupá Gold Project in Brazil, which features advanced processing facilities and significant mineral reserves and resources. Aura Minerals reported strong revenue growth in 2025 driven by higher metal prices and increased production from new mines. The company maintains a diversified customer base and manages financial obligations through loans, debentures, and credit facilities with established covenants. Exploration activities continue to support resource expansion near existing projects.

TOYO Co., Ltd operates in the solar energy sector, manufacturing solar cells and modules and providing facilitation and OEM services. The company has a single operating segment and generates most of its revenue from the USA, with additional operations in Vietnam, Singapore, Ethiopia, China, and Japan. TOYO has expanded its US manufacturing capacity through acquisition of Solar Plus Technology Texas LLC and commissioning of a 1GW solar module plant in Houston, Texas. The company has a concentrated customer base, with a few customers accounting for a large portion of revenues and accounts receivable. TOYO's financials show growth in revenues and profitability over recent years but also highlight liquidity challenges with significant working capital deficits and reliance on financing from related parties and investors. The company recognizes revenue primarily in US Dollars, with some subsidiaries operating in local currencies subject to foreign exchange controls. Recent leadership changes bring experienced management focused on energy infrastructure and decarbonization.

A2Z Cust2Mate Solutions Corp. is an innovative technology company incorporated in Canada with operational offices in Israel and a U.S. subsidiary. The company develops and commercializes retail smart cart solutions (Cust2Mate Products) designed for large grocery stores and supermarkets, manufactures precision metal parts, provides maintenance services in Israel, and develops vehicle safety technology. Since 2020, the company has focused on expanding its smart cart business, which features mobile self-checkout carts equipped with touch screens, proprietary software, and anti-fraud technologies. The smart carts enable real-time item scanning, mobile payments, and digital advertising services. The company generates revenue through upfront fees and recurring monthly subscriptions under multiyear agreements, supplemented by a retail media platform that monetizes advertising and commissions. Key customers include large Israeli retailers such as Yochananof and Super Sapir, with strategic partnerships for deployment in France, Mexico, and Central America. The company reported $7.9 million in revenue for 2025, with 41% from smart carts and 59% from precision metal parts. Despite recurring net losses, the company maintains a strong liquidity position and continues to invest in research and development to support growth.

Capstone Companies, Inc. was historically engaged in designing, promoting, and licensing consumer products aimed at simplifying daily living through technology. Its most recent product, the Connected Chef kitchen tablet, was not successfully commercialized in 2025, leading to termination of its licensing agreement. The company ceased promotion of its LED Lighting product line in 2023 and ended the Smart Mirror product line in 2024 due to poor sales. In 2024 and 2025, Capstone pursued development of a new business line in the health, fitness, and social activities (HFS) industry but did not acquire or develop any operations by the end of 2025. The company relies on unsecured promissory notes from related parties, including Coppermine Ventures LLC and eBliss Global, for working capital. As of late 2025 and early 2026, Capstone has no revenue-generating business or products in active commercialization and faces significant liquidity constraints and going concern risks.

Generation Income Properties, Inc. is a publicly traded company listed on The Nasdaq Stock Market under the ticker GIPR. The company operates in real estate, having sold office and retail properties in late 2025. It reported revenue of approximately $9.74 million and a net loss of approximately $10.34 million for the fiscal year ended December 31, 2025. The company holds cash and cash equivalents of approximately $6.16 million as of the same date. It has faced Nasdaq listing compliance challenges, including a minimum bid price deficiency, and has engaged in appeals and strategic reviews to address these issues. Leadership changes and a consulting agreement were announced in early 2026, alongside the conclusion of a special committee's review of strategic alternatives.

Genenta Science S.p.A. operates as a clinical-stage biotechnology company focused on developing gene therapies for solid tumors using a novel platform that modifies hematopoietic stem/progenitor cells to deliver immunomodulatory molecules to tumors via Tie2 Expressing Monocytes (TEMs). The technology aims to treat a broad range of cancers by leveraging the natural tumor-homing properties of TEMs. The company has no approved products or commercial revenue and has historically funded operations through equity and convertible debt financings. It is undergoing a strategic transformation to become an industrial consolidator acquiring majority stakes in privately held Italian companies within national-security regulated sectors under Italy's Golden Power legislation, including biotechnology, defense, aerospace, cybersecurity, and related fields. This strategy involves acquiring companies with established profitability and integrating them to enhance operational and financial performance. Genenta has recently entered a binding offer to acquire a majority stake in Sòphia High Tech, an aerospace and defense engineering firm, as part of this transformation. The company maintains strong liquidity with cash and marketable securities totaling approximately €28.1 million as of December 31, 2025, and continues to invest in research and development of its gene therapy candidates while managing operating expenses.

Idea Acquisition Corp. is a Cayman Islands-incorporated special purpose acquisition company (SPAC) that completed its IPO in February 2026, raising $350 million through the issuance of units consisting of Class A ordinary shares and redeemable warrants. The company simultaneously completed a private placement of warrants to its sponsor and underwriters. The proceeds from these offerings are held in a trust account with restrictions on their release until the completion of an initial business combination or other specified events. As of the fiscal year ended December 31, 2025, the company reported no cash on hand, current liabilities of approximately $365,000, and a net loss of $48,912. The company has not disclosed any revenue or operational details, consistent with its status as a SPAC prior to a business combination.

Universal Token, Inc. is a financial technology company incorporated in Wyoming in 2021, focused on developing an open-source blockchain platform (UTKN) for tokenizing real-world assets (RWA), such as commodities like gold. The platform is designed to enable secure transfer of digital assets across wallets with comprehensive KYC and AML processes. The company targets central and local banks for platform integration, involving backend programming and currency conversions. Custody of tokens remains with customers. Universal Token is in the process of obtaining regulatory licenses in El Salvador and plans to expand licensing to other countries including UAE and Thailand. The company has limited operational scale with one full-time employee and one part-time CTO, and its corporate offices are in El Salvador with operations across Central America and Asia. Financially, the company reported no revenue and a net loss for the fiscal year ending December 31, 2025, with current liabilities exceeding current assets [S1].

PAID INC offers a comprehensive platform for small and medium businesses to establish and manage e-commerce operations, including website creation, payment processing, multi-channel sales management, and shipping coordination. Its PaidCart, PaidPayments, and PaidShipping products integrate to provide a seamless experience from online sales to delivery. The company leverages partnerships with leading carriers to offer discounted shipping rates and multi-courier comparison tools. It actively markets to small businesses and partners with associations, particularly in Canada. Recent operational focus has been on expanding shipping coordination services amid shifts in carrier usage.

Crown PropTech Acquisitions is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in 2020. Its sole purpose is to identify and complete a business combination with one or more target companies. The company completed its initial public offering in February 2021, raising gross proceeds of $276 million, which were placed in a Trust Account invested in U.S. government securities. The company has not generated any operating revenues and has incurred net losses related to operating costs and expenses associated with being a public company and pursuing a business combination. It is currently engaged in a proposed business combination with Mkango Rare Earths Limited and related entities, with the agreement amended to extend the deadline for completion to September 30, 2026, with a possible extension to December 31, 2026. The company’s financial position as of December 31, 2025, shows a working capital deficit and limited cash outside the Trust Account, with the Trust Account funds restricted for use in the business combination or shareholder redemptions.

ENDRA Life Sciences Inc. focuses on developing and commercializing Thermo-Acoustic Enhanced Ultrasound (TAEUS) technology, which aims to improve ultrasound imaging quality and diagnostic capabilities. The company’s product portfolio includes devices targeting liver imaging applications, such as the MASLD TAEUS device and the TAEUS FLIP System. ENDRA has obtained CE mark approval for marketing in the European Union and is pursuing FDA regulatory clearance in the United States through a de novo classification process. The company relies on third-party manufacturers and is building sales and marketing capabilities to support commercialization. ENDRA also explores opportunities in digital assets and cryptocurrency as part of its portfolio expansion. The company has a history of operating losses and requires additional capital to support ongoing development and commercialization efforts.

Nuburu, Inc. specializes in high-powered blue laser technology products and related installation services. The company serves customers primarily in the United States, Europe, and Asia. Revenue recognition follows standard accounting principles, with product sales recognized at a point in time and installation services recognized over time. Despite historical revenue generation, Nuburu did not record revenue in 2025 and continues to operate at a net loss, reflecting its developmental stage and ongoing commercialization efforts. The company has taken cost reduction measures including employee furloughs, which have impacted operations. Nuburu is actively pursuing strategic initiatives including acquisitions, joint ventures, and investments to expand its technology applications, especially in defense and security sectors. It has also engaged in multiple financing activities to support its operations and growth plans. The company faced a trading halt due to low stock price but implemented a reverse stock split to regain compliance with NYSE American listing standards. It is currently under a compliance plan with the exchange.

Alpha Cognition Inc. operates as a biopharmaceutical company dedicated to developing treatments for neurodegenerative diseases, with a primary focus on Alzheimer's disease. The company’s flagship product, ZUNVEYL (benzgalantamine), is a next-generation acetylcholinesterase inhibitor approved by the FDA in July 2024 and commercially launched in March 2025. ZUNVEYL is designed to provide symptomatic relief for mild to moderate Alzheimer's disease with a differentiated mechanism and improved tolerability profile, particularly minimizing gastrointestinal side effects. The company targets the long-term care market in the U.S., leveraging a specialty sales force and engaging with Medicare payors and pharmacy benefit managers to expand formulary coverage. Alpha Cognition also pursues pre-clinical development of additional formulations and combination therapies, including sublingual ALPHA-1062 for mild traumatic brain injury and combination with memantine for moderate-to-severe Alzheimer's disease. The company maintains strong liquidity with $66 million in cash and equivalents as of year-end 2025 but has incurred significant net losses since inception. It faces competition from established symptomatic treatments and emerging disease-modifying therapies but aims to differentiate through clinical benefits and tolerability.

Edible Garden AG Inc operates in the indoor agriculture and consumer packaged goods sectors, focusing on fresh produce and sustainable agriculture products. The company sells primarily to national and local supermarket chains, with a high concentration of revenue from a few customers. It owns or controls growing facilities in Michigan and New Jersey and uses third-party contract growers. The company has developed proprietary forecasting software (GreenThumb) to manage supply and demand. Recent strategic initiatives include launching new product lines such as Pickle Party™, Pulp®, and Kick. Sports Nutrition, expanding distribution through major retailers, acquiring NaturalShrimp assets, and developing a ready-to-drink beverage manufacturing platform at its Iowa facility. The company has a history of significant net losses and liquidity challenges, with auditors expressing substantial doubt about its ability to continue as a going concern. Edible Garden faces competitive pressures, low industry margins, customer concentration risks, and environmental risks related to weather and climate change.

Alset Inc. is a diversified holding company engaged through subsidiaries in real estate development, digital transformation technologies, biohealth activities, and consumer products. Its operations span the United States, Singapore, Hong Kong, Australia, South Korea, and China. The company manages its principal businesses primarily through its 85.8% owned subsidiary, Alset International Limited, publicly traded on the Singapore Stock Exchange. The real estate segment focuses on land subdivision developments near Houston, Texas, including the Lakes at Black Oak project and the Alset Villas community, with a portfolio of 132 single-family rental homes equipped with smart home and solar technologies. The digital transformation technology segment provides B2B solutions in e-commerce, collaboration, social networking, and incorporates advanced technologies such as AI and metaverse services. The biohealth segment develops, manufactures, licenses, and distributes health-related products, with operations in Korea and the US. The company completed the acquisition of New Energy Asia Pacific Inc. in 2025, expanding into the distribution of all-electric special-purpose and transportation vehicles, charging stations, and batteries. Alset Inc. reported revenue of approximately $4.5 million and a net loss of about $47.4 million for the fiscal year ended December 31, 2025, with strong liquidity ratios indicating a solid short-term financial position. The company operates with a holding company structure and depends on earnings and distributions from its subsidiaries to meet obligations. It faces competitive and operational risks and is actively managing a material weakness in internal controls related to staffing.[S1][S2]

Fortress Biotech, Inc. operates as a biopharmaceutical company through a network of subsidiaries and partner companies engaged in the development and commercialization of pharmaceutical products across various therapeutic areas. The company provides business, scientific, regulatory, legal, and financial support to its subsidiaries, which include publicly traded entities such as Journey Medical Corporation, Mustang Bio, and Avenue Therapeutics, as well as private subsidiaries. Fortress's business model centers on acquiring or licensing intellectual property and advancing product candidates through development, regulatory approval, and commercialization. The company generates revenue primarily through product sales by its subsidiaries, collaboration agreements, and milestone payments. Fortress also raises capital through equity and debt offerings, warrant exercises, and asset sales to fund operations and growth initiatives. The company maintains contractual arrangements with specialty pharmacies and commercial payers, including rebates and product return policies consistent with industry standards. Fortress's consolidated financial position as of December 31, 2025, reflects total assets of approximately $185.5 million and stockholders' equity of $62.2 million, supported by liquidity measures indicating operational funding sufficiency for at least 12 months post-filing.

Decoy Therapeutics Inc. is a biotechnology company at the pre-clinical stage, specializing in peptide conjugate therapeutics engineered through its proprietary IMP 3 ACT™ platform. This platform leverages machine learning and artificial intelligence alongside fast-flow synthesis to rapidly design and manufacture peptide conjugates targeting serious unmet medical needs, primarily in infectious diseases and oncology. The company emerged from a merger completed in November 2025 between Salarius Pharmaceuticals and Legacy Decoy, resulting in a combined entity renamed Decoy Therapeutics Inc. in January 2026. The merger integrated complementary drug development approaches, including legacy small molecule clinical candidates and the novel peptide conjugate platform. The company has no approved products or revenues and is advancing multiple drug development programs, including a lead pan-Coronavirus antiviral prophylactic targeting immunocompromised patients, supported by significant non-dilutive funding. It plans to file an IND application in the first half of 2027 and is pursuing strategic partnerships and platform manufacturing capabilities. The company maintains Nasdaq listing compliance through reverse stock splits and regulatory appeals and reported a net loss of $12.5 million for the year ended December 31, 2025, with cash and equivalents of approximately $10.7 million.